Association of shorter telomere length with essential hypertension in Indian population

American Journal of Human Biology

Volumn 24, Issue 4, 2012, Pages 573-578

  Bhupatiraju, Charita ^a   Saini, Divyalakshmi ^b   Patkar, Sushma ^a   Deepak, P ^c   Das, Birajalaxmi ^b   Padma, T ^a  

^a OSMANIA UNIVERSITY   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

^c GANDHI MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUORESCENT DYE;

ADULT; AGED; ARTICLE; CHEMISTRY; CYTOLOGY; FEMALE; GENETICS; HUMAN; HYPERTENSION; INDIA; LEUKOCYTE; MALE; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FLUORESCENT DYES; HUMANS; HYPERTENSION; INDIA; LEUKOCYTES; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; TELOMERE;

EID: 84862130589     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.22264     Document Type: Article

References (49)

1. Adaikalakoteswari A, Balasubramanyam M, Mohan V. 2005. Telomere shortening occurs in Asian Indian type 2 diabetic patients. Diabetic Med 22: 1151-1156.
2. Adaikalakoteswari A, Balasubramanyam M, Ravikumar R, Deepa R, Mohan V. 2007. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis 195: 83-89.
3. Aviv A. 2002. Chronology versus biology telomeres, essential hypertension, and vascular aging. Hypertension 40: 229-232.
4. Aviv A. 2009. Leukocyte telomere length, hypertension, and atherosclerosis: are there potential mechanistic explanations? Hypertension 53: 590-591.
5. Aviv A, Aviv H. 1999. Telomeres and essential hypertension. Am J Hypertens 12: 427-432.
6. Aviv A, Hunt SC, Lin J, Cao X, Kimura M, Blackburn E. 2011. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res 39:e134.
7. Aydos SE, Tukun A. 2007. Does telomere length affect blood pressure? Adv Ther 24: 269-272.
8. Balasubramanyam M, Adaikalakoteswari A, Monickaraj SF, Mohan V. 2007. Telomere shortening and metabolic/vascular diseases. Indian J Med Res 125: 441-450.
9. Benetos A, Gardner JP, Kimura M, Labat C, Nzietchueng R, Dousset B, Zannad F, Lacolley P, Aviv A. 2005. Aldosterone and telomere length in white blood cells. J Gerontol A Biol Sci Med Sci 60: 1593-1596.
10. Cawthon RM. 2002. Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
11. Ceriello A, Motz E. 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The common soil hypothesis revisted. Arterioscler Thromb Vasc Biol 24: 816-823.
12. Das B, Pawar N, Saini D, Seshadri M. 2009. Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals. BMC Med Genet 10: 99.
13. Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A, Kimura M, Larson MG, Meigs JB, Keaney JF, Aviv A. 2006. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 5: 325-330.
14. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. 2004. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101: 17312-1731.
15. Facchini FS, Hua N, Abbasi F, Reaven GM. 2001. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86: 3574-3578.
16. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, Whooley MA. 2010. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS ONE 5: e8612.
17. Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Walston J, Kimura M, Aviv A. 2007. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 65: 14-21.
18. Frenck RWJr, Blackburn EH, Shannon KM. 1998. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 95: 5607-5610.
19. Griendling KK, Alexander RW. 1997. Oxidative stress and cardiovascular disease [editorial; comment]. Circulation 96: 3264-3265.
20. Grodstein F, van Oijen M, Irizarry MC, Rosas HD, Hyman BT, Growdon JH, De Vivo E. 2008. Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study. PLoS ONE 3: e1590.
21. Gupta PC, Gupta R, Pendnekar MS. 2004. Hypertension prevalence and blood pressure trends in 88653 subjects in Mumbai, India. J Hum Hypertension 18: 853-856.
22. Hewakapuge S, Roland AH, van Oorschot B, Paul Lewandowski C, Swati Baindur-Hudson. 2008. Investigation of telomere lengths measurement by quantitative real-time PCR to predict age. Legal Med 10: 236-242.
23. Hypertension study Group. 2001. Prevalence, awareness, treatment and control of hypertension among elderly in Bangladesh and India: a multicentric study. Bull World Health Organ 79: 490-500.
24. Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, Warram JH, Aviv A. 1998. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 47: 480-486.
25. Jeanclos E, Schork NJ, Kyvik KO, Kimura M, Skurnick JH, Aviv A. 2000. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 36: 195-200.
26. Jennings BJ, Ozanne SE, Hales CN. 2000. Nutrition, oxidative damage, telomere shortening, and cellular senescence: individual or connected agents of aging? Mol Genet Metab 71: 32-42.
27. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. 2005. Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-223.
28. Kedziora-Kornatowska K, Czuczejko J, Pawluk H, Kornatowski T, Motyl J. 2004. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 9: 635-641.
29. Lahiri K, Nurnberger JIJr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic acids Res 19: 5444.
30. Lung FW, Ku CS, Kao WT. 2008. Telomere length may be associated with hypertension. J Hum Hypertens 22: 230-232.
31. Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning MA, Svenson U, Roos G, Dean Hosgood HIII, Shen M, Wei Q. 2011. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 6: e20466.
32. McGrath M, Wong JYY, Michaud D, Hunter DJ, De Vivo I. 2007. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 16: 815-819.
33. Miyajima K, Minatoguchi S, Ito Y, Hukunishi M, Matsuno Y, Kakami M, Kawasaki M, Nishigaki K, Takemura G, Fujiwara H. 2007. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension. Hypertens Res 30: 307-313.
34. Mukherjee M, Brouilette S, Stevens S, Shetty KR, Samani NJ. 2009. Association of shorter telomeres with coronary artery disease in Indian subjects. Heart 95: 669-673.
35. Nordfjäll K, Svenson U, Norrback KF, Adolfsson R, Lenner P, Roos G. 2009. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genet 5: e1000375.
36. Raynaud CM, Jang SJ, Nuciforo P, Lantuejoul S, Brambilla E, Mounier N, Olaussen KA, André F, Morat L, Sabatier L, Soria JC. 2008. Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol 19: 1875-1881.
37. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP. 2007. Relationship between oxidative stress and essential hypertension. Hypertens Res 30: 1159-1167.
38. Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G. 2003. Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension. J Cardiovasc Pharmacol 42: 453-461.
39. Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. 2004. Insulin resistance and hypertension: the insulin resistance atherosclerosis study. Hypertension 43: 1324-1331.
40. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. 2006. Monocyte telomere shortening and oxidative DNA damage in Type 2 diabetes. Diabetes Care 29: 283-289.
41. SigmaStat Software Version 3.5, 2006, Systat software, Inc. USA. Available at:.
42. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A, Opacie M, Matic D, Ivanovic B, Simic T. 2006. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different Rodrigo et al.: blood pressure and oxidative stress 1167 degrees of essential hypertension. J Hum Hypertens 20: 149-155.
43. Sowers JR, Frohlich ED. 2004. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Med Clin North Am 88: 63-82.
44. Staessen JA, Wang J, Bianchi G, Birkenhager WH. 2003. Essential hypertension. Lancet 361; 1629-1641.
45. Starr JM, Shiels PG, Harris SE, Pattie A, Pearce MS, Relton CL, Deary IJ. 2008. Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79 years from the 1932 Scottish Mental Survey. Mech Ageing Dev 129: 745-751.
46. Van der Harst P, Van der Steege G, de Boer RA, Voors AA, Hall AS, Marcel J, Van Gilst MH, van Veldhuisen DJ. 2007. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 49: 1459-1464.
47. von Zglinicki T. 2002. Oxidative stress shortens telomeres. Trends Biochem Sci 27: 339-344.
48. Wang Z, Rhee DB, Lu J, Bohr CT, Zhou F, Vallabhaneni H, de Souza-Pinto NC, Liu Y. 2010. Characterization of oxidative guanine damage and repair in mammalian telomeres. PLoS Genet 6: e1000951.
49. Yang Z, Huang X, Jiang H, Zhang Y, Liu H, Qin C, Eisner GM, Jose P, Rudolph L, Ju Z. 2009. Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 53: 639-645.